nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2E1—lung cancer	0.174	0.656	CbGaD
Nicardipine—ABCB1—lung cancer	0.091	0.344	CbGaD
Nicardipine—CYP3A5—Gefitinib—lung cancer	0.0181	0.0446	CbGbCtD
Nicardipine—CYP3A5—Teniposide—lung cancer	0.0176	0.0432	CbGbCtD
Nicardipine—CYP2C19—Gefitinib—lung cancer	0.0146	0.0359	CbGbCtD
Nicardipine—CYP2C19—Teniposide—lung cancer	0.0142	0.0349	CbGbCtD
Nicardipine—ABCB1—Topotecan—lung cancer	0.0129	0.0317	CbGbCtD
Nicardipine—CYP2B6—Irinotecan—lung cancer	0.0123	0.0302	CbGbCtD
Nicardipine—CYP2C9—Gefitinib—lung cancer	0.0122	0.0299	CbGbCtD
Nicardipine—ABCB1—Gefitinib—lung cancer	0.0118	0.029	CbGbCtD
Nicardipine—CYP2C9—Teniposide—lung cancer	0.0118	0.029	CbGbCtD
Nicardipine—CYP2D6—Gefitinib—lung cancer	0.0111	0.0273	CbGbCtD
Nicardipine—CYP3A5—Crizotinib—lung cancer	0.0111	0.0273	CbGbCtD
Nicardipine—CYP3A5—Erlotinib—lung cancer	0.0107	0.0263	CbGbCtD
Nicardipine—CYP2C8—Erlotinib—lung cancer	0.0103	0.0253	CbGbCtD
Nicardipine—CYP2B6—Cisplatin—lung cancer	0.01	0.0246	CbGbCtD
Nicardipine—CYP2E1—Etoposide—lung cancer	0.00999	0.0245	CbGbCtD
Nicardipine—CYP3A5—Paclitaxel—lung cancer	0.00982	0.0241	CbGbCtD
Nicardipine—CYP3A5—Irinotecan—lung cancer	0.00969	0.0238	CbGbCtD
Nicardipine—CYP2C8—Paclitaxel—lung cancer	0.00944	0.0232	CbGbCtD
Nicardipine—ABCB1—Vinorelbine—lung cancer	0.0091	0.0223	CbGbCtD
Nicardipine—CYP2D6—Vinorelbine—lung cancer	0.00857	0.0211	CbGbCtD
Nicardipine—CYP3A5—Etoposide—lung cancer	0.00776	0.0191	CbGbCtD
Nicardipine—CYP3A4—Topotecan—lung cancer	0.00774	0.019	CbGbCtD
Nicardipine—CYP2C8—Etoposide—lung cancer	0.00746	0.0183	CbGbCtD
Nicardipine—ABCB1—Crizotinib—lung cancer	0.00724	0.0178	CbGbCtD
Nicardipine—CYP3A5—Docetaxel—lung cancer	0.0071	0.0174	CbGbCtD
Nicardipine—CYP3A4—Gefitinib—lung cancer	0.00708	0.0174	CbGbCtD
Nicardipine—ABCB1—Gemcitabine—lung cancer	0.00708	0.0174	CbGbCtD
Nicardipine—ABCB1—Erlotinib—lung cancer	0.00698	0.0171	CbGbCtD
Nicardipine—CYP3A4—Teniposide—lung cancer	0.00686	0.0169	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—lung cancer	0.00672	0.0165	CbGbCtD
Nicardipine—CYP2C9—Paclitaxel—lung cancer	0.00659	0.0162	CbGbCtD
Nicardipine—CYP2D6—Erlotinib—lung cancer	0.00658	0.0162	CbGbCtD
Nicardipine—ABCB1—Paclitaxel—lung cancer	0.00639	0.0157	CbGbCtD
Nicardipine—ABCB1—Irinotecan—lung cancer	0.00631	0.0155	CbGbCtD
Nicardipine—ABCB1—Vinblastine—lung cancer	0.00561	0.0138	CbGbCtD
Nicardipine—CYP3A4—Vinorelbine—lung cancer	0.00545	0.0134	CbGbCtD
Nicardipine—CYP2C9—Cisplatin—lung cancer	0.0053	0.013	CbGbCtD
Nicardipine—CYP2D6—Vinblastine—lung cancer	0.00528	0.013	CbGbCtD
Nicardipine—ABCB1—Cisplatin—lung cancer	0.00514	0.0126	CbGbCtD
Nicardipine—ABCB1—Etoposide—lung cancer	0.00505	0.0124	CbGbCtD
Nicardipine—ABCB1—Docetaxel—lung cancer	0.00462	0.0113	CbGbCtD
Nicardipine—CYP3A4—Crizotinib—lung cancer	0.00434	0.0107	CbGbCtD
Nicardipine—CYP3A4—Erlotinib—lung cancer	0.00418	0.0103	CbGbCtD
Nicardipine—CYP3A4—Paclitaxel—lung cancer	0.00383	0.00941	CbGbCtD
Nicardipine—CYP3A4—Irinotecan—lung cancer	0.00378	0.00928	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—lung cancer	0.00345	0.00846	CbGbCtD
Nicardipine—CYP3A4—Vinblastine—lung cancer	0.00336	0.00825	CbGbCtD
Nicardipine—ABCB1—Methotrexate—lung cancer	0.00334	0.0082	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—lung cancer	0.00325	0.00797	CbGbCtD
Nicardipine—CYP3A4—Etoposide—lung cancer	0.00303	0.00743	CbGbCtD
Nicardipine—CYP3A4—Docetaxel—lung cancer	0.00277	0.0068	CbGbCtD
Nicardipine—CYP3A4—Doxorubicin—lung cancer	0.00206	0.00507	CbGbCtD
Nicardipine—CACNA2D1—mammary gland—lung cancer	0.00137	0.0525	CbGeAlD
Nicardipine—CALM3—mammary gland—lung cancer	0.000983	0.0378	CbGeAlD
Nicardipine—CHRM5—epithelium—lung cancer	0.000785	0.0302	CbGeAlD
Nicardipine—CACNA1C—respiratory system—lung cancer	0.000782	0.0301	CbGeAlD
Nicardipine—Nimodipine—AHR—lung cancer	0.000774	0.207	CrCbGaD
Nicardipine—CALM1—mammary gland—lung cancer	0.000768	0.0296	CbGeAlD
Nicardipine—ADRA1D—epithelium—lung cancer	0.000702	0.027	CbGeAlD
Nicardipine—PDE1A—lung—lung cancer	0.000698	0.0269	CbGeAlD
Nicardipine—CACNB2—cardiac atrium—lung cancer	0.000673	0.0259	CbGeAlD
Nicardipine—CYP2C8—mammary gland—lung cancer	0.00064	0.0246	CbGeAlD
Nicardipine—CACNA1D—cardiac atrium—lung cancer	0.000588	0.0226	CbGeAlD
Nicardipine—PDE1B—lymph node—lung cancer	0.00057	0.0219	CbGeAlD
Nicardipine—CYP2C9—mammary gland—lung cancer	0.000568	0.0219	CbGeAlD
Nicardipine—CACNA1C—cardiac atrium—lung cancer	0.000543	0.0209	CbGeAlD
Nicardipine—CALM3—bronchus—lung cancer	0.000539	0.0207	CbGeAlD
Nicardipine—CACNA2D1—bone marrow—lung cancer	0.000533	0.0205	CbGeAlD
Nicardipine—CACNB2—lung—lung cancer	0.000515	0.0198	CbGeAlD
Nicardipine—CALM2—respiratory system—lung cancer	0.000514	0.0198	CbGeAlD
Nicardipine—CALM1—respiratory system—lung cancer	0.000512	0.0197	CbGeAlD
Nicardipine—CALM3—trachea—lung cancer	0.000484	0.0186	CbGeAlD
Nicardipine—CACNA2D1—lung—lung cancer	0.000483	0.0186	CbGeAlD
Nicardipine—PDE1A—lymph node—lung cancer	0.000477	0.0184	CbGeAlD
Nicardipine—Nifedipine—ABCC3—lung cancer	0.000471	0.126	CrCbGaD
Nicardipine—CALM3—cardiac atrium—lung cancer	0.000455	0.0175	CbGeAlD
Nicardipine—CACNA1D—lung—lung cancer	0.00045	0.0173	CbGeAlD
Nicardipine—CHRM1—trachea—lung cancer	0.000434	0.0167	CbGeAlD
Nicardipine—CALM2—epithelium—lung cancer	0.00043	0.0165	CbGeAlD
Nicardipine—CALM1—epithelium—lung cancer	0.000428	0.0165	CbGeAlD
Nicardipine—CALM2—bronchus—lung cancer	0.000423	0.0163	CbGeAlD
Nicardipine—CALM1—bronchus—lung cancer	0.000421	0.0162	CbGeAlD
Nicardipine—CACNA1C—lung—lung cancer	0.000415	0.016	CbGeAlD
Nicardipine—ADRA1A—epithelium—lung cancer	0.000403	0.0155	CbGeAlD
Nicardipine—CYP3A5—respiratory system—lung cancer	0.000385	0.0148	CbGeAlD
Nicardipine—CALM3—bone marrow—lung cancer	0.000384	0.0148	CbGeAlD
Nicardipine—CYP2B6—respiratory system—lung cancer	0.000382	0.0147	CbGeAlD
Nicardipine—CALM2—trachea—lung cancer	0.00038	0.0146	CbGeAlD
Nicardipine—CALM1—trachea—lung cancer	0.000378	0.0146	CbGeAlD
Nicardipine—CYP2E1—respiratory system—lung cancer	0.000359	0.0138	CbGeAlD
Nicardipine—CALM2—cardiac atrium—lung cancer	0.000357	0.0137	CbGeAlD
Nicardipine—CALM1—cardiac atrium—lung cancer	0.000355	0.0137	CbGeAlD
Nicardipine—CACNB2—lymph node—lung cancer	0.000352	0.0135	CbGeAlD
Nicardipine—CALM3—lung—lung cancer	0.000348	0.0134	CbGeAlD
Nicardipine—Nilvadipine—CYP2A6—lung cancer	0.000332	0.0889	CrCbGaD
Nicardipine—CACNA2D1—lymph node—lung cancer	0.000331	0.0127	CbGeAlD
Nicardipine—CYP2B6—bronchus—lung cancer	0.000315	0.0121	CbGeAlD
Nicardipine—CHRM1—lung—lung cancer	0.000312	0.012	CbGeAlD
Nicardipine—CACNA1D—lymph node—lung cancer	0.000308	0.0118	CbGeAlD
Nicardipine—CALM2—bone marrow—lung cancer	0.000301	0.0116	CbGeAlD
Nicardipine—CALM1—bone marrow—lung cancer	0.0003	0.0115	CbGeAlD
Nicardipine—Amlodipine—CYP2A6—lung cancer	0.000286	0.0766	CrCbGaD
Nicardipine—CACNA1C—lymph node—lung cancer	0.000284	0.0109	CbGeAlD
Nicardipine—CALM2—lung—lung cancer	0.000273	0.0105	CbGeAlD
Nicardipine—CALM1—lung—lung cancer	0.000272	0.0105	CbGeAlD
Nicardipine—Clevidipine—CYP2E1—lung cancer	0.000263	0.0704	CrCbGaD
Nicardipine—Nifedipine—CYP2A6—lung cancer	0.000256	0.0685	CrCbGaD
Nicardipine—CALM3—lymph node—lung cancer	0.000238	0.00915	CbGeAlD
Nicardipine—Nilvadipine—CYP2E1—lung cancer	0.000236	0.0631	CrCbGaD
Nicardipine—ABCB1—respiratory system—lung cancer	0.000204	0.00786	CbGeAlD
Nicardipine—CYP3A5—lung—lung cancer	0.000204	0.00786	CbGeAlD
Nicardipine—CYP2B6—lung—lung cancer	0.000203	0.00781	CbGeAlD
Nicardipine—Amlodipine—CYP1A1—lung cancer	0.0002	0.0536	CrCbGaD
Nicardipine—CYP2E1—lung—lung cancer	0.000191	0.00733	CbGeAlD
Nicardipine—CALM2—lymph node—lung cancer	0.000187	0.00719	CbGeAlD
Nicardipine—CALM1—lymph node—lung cancer	0.000186	0.00715	CbGeAlD
Nicardipine—Nifedipine—CYP2E1—lung cancer	0.000182	0.0486	CrCbGaD
Nicardipine—Nifedipine—CYP1A1—lung cancer	0.000179	0.048	CrCbGaD
Nicardipine—ABCB1—epithelium—lung cancer	0.000171	0.00657	CbGeAlD
Nicardipine—ABCB1—trachea—lung cancer	0.000151	0.00581	CbGeAlD
Nicardipine—Nisoldipine—ABCB1—lung cancer	0.000132	0.0354	CrCbGaD
Nicardipine—Nitrendipine—ABCB1—lung cancer	0.000124	0.0331	CrCbGaD
Nicardipine—ABCB1—bone marrow—lung cancer	0.00012	0.00461	CbGeAlD
Nicardipine—Dyspnoea—Gemcitabine—lung cancer	0.000116	0.000812	CcSEcCtD
Nicardipine—Chest pain—Etoposide—lung cancer	0.000116	0.000811	CcSEcCtD
Nicardipine—Nausea—Vinblastine—lung cancer	0.000115	0.00081	CcSEcCtD
Nicardipine—Somnolence—Gemcitabine—lung cancer	0.000115	0.000809	CcSEcCtD
Nicardipine—Hypertension—Paclitaxel—lung cancer	0.000115	0.000806	CcSEcCtD
Nicardipine—Discomfort—Etoposide—lung cancer	0.000114	0.000801	CcSEcCtD
Nicardipine—Pain—Irinotecan—lung cancer	0.000114	0.000799	CcSEcCtD
Nicardipine—Constipation—Irinotecan—lung cancer	0.000114	0.000799	CcSEcCtD
Nicardipine—Arthralgia—Paclitaxel—lung cancer	0.000113	0.000795	CcSEcCtD
Nicardipine—Chest pain—Paclitaxel—lung cancer	0.000113	0.000795	CcSEcCtD
Nicardipine—Myalgia—Paclitaxel—lung cancer	0.000113	0.000795	CcSEcCtD
Nicardipine—Hypotension—Cisplatin—lung cancer	0.000113	0.000793	CcSEcCtD
Nicardipine—Anxiety—Paclitaxel—lung cancer	0.000113	0.000792	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—lung cancer	0.000113	0.000792	CcSEcCtD
Nicardipine—Nausea—Topotecan—lung cancer	0.000112	0.000787	CcSEcCtD
Nicardipine—Discomfort—Paclitaxel—lung cancer	0.000112	0.000786	CcSEcCtD
Nicardipine—Confusional state—Etoposide—lung cancer	0.000112	0.000784	CcSEcCtD
Nicardipine—Pain—Gemcitabine—lung cancer	0.000111	0.000779	CcSEcCtD
Nicardipine—Constipation—Gemcitabine—lung cancer	0.000111	0.000779	CcSEcCtD
Nicardipine—Nausea—Erlotinib—lung cancer	0.000111	0.000779	CcSEcCtD
Nicardipine—Dry mouth—Paclitaxel—lung cancer	0.000111	0.000778	CcSEcCtD
Nicardipine—Diarrhoea—Vinorelbine—lung cancer	0.00011	0.000775	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00011	0.000773	CcSEcCtD
Nicardipine—Infection—Etoposide—lung cancer	0.00011	0.000772	CcSEcCtD
Nicardipine—Feeling abnormal—Irinotecan—lung cancer	0.00011	0.00077	CcSEcCtD
Nicardipine—Confusional state—Paclitaxel—lung cancer	0.00011	0.000769	CcSEcCtD
Nicardipine—Gastrointestinal pain—Irinotecan—lung cancer	0.000109	0.000764	CcSEcCtD
Nicardipine—Oedema—Paclitaxel—lung cancer	0.000109	0.000762	CcSEcCtD
Nicardipine—Paraesthesia—Cisplatin—lung cancer	0.000109	0.000762	CcSEcCtD
Nicardipine—ABCB1—lung—lung cancer	0.000109	0.00417	CbGeAlD
Nicardipine—Thrombocytopenia—Etoposide—lung cancer	0.000108	0.000761	CcSEcCtD
Nicardipine—Tachycardia—Etoposide—lung cancer	0.000108	0.000759	CcSEcCtD
Nicardipine—Infection—Paclitaxel—lung cancer	0.000108	0.000757	CcSEcCtD
Nicardipine—Dyspnoea—Cisplatin—lung cancer	0.000108	0.000757	CcSEcCtD
Nicardipine—Erectile dysfunction—Methotrexate—lung cancer	0.000107	0.000754	CcSEcCtD
Nicardipine—Hyperhidrosis—Etoposide—lung cancer	0.000107	0.000752	CcSEcCtD
Nicardipine—Feeling abnormal—Gemcitabine—lung cancer	0.000107	0.00075	CcSEcCtD
Nicardipine—Shock—Paclitaxel—lung cancer	0.000107	0.00075	CcSEcCtD
Nicardipine—Dizziness—Vinorelbine—lung cancer	0.000107	0.000749	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000107	0.000749	CcSEcCtD
Nicardipine—Amlodipine—ABCB1—lung cancer	0.000106	0.0285	CrCbGaD
Nicardipine—Hypokalaemia—Doxorubicin—lung cancer	0.000106	0.000747	CcSEcCtD
Nicardipine—Thrombocytopenia—Paclitaxel—lung cancer	0.000106	0.000746	CcSEcCtD
Nicardipine—Tachycardia—Paclitaxel—lung cancer	0.000106	0.000744	CcSEcCtD
Nicardipine—Abdominal pain—Irinotecan—lung cancer	0.000105	0.000739	CcSEcCtD
Nicardipine—Body temperature increased—Irinotecan—lung cancer	0.000105	0.000739	CcSEcCtD
Nicardipine—Hyperhidrosis—Paclitaxel—lung cancer	0.000105	0.000737	CcSEcCtD
Nicardipine—Hypotension—Etoposide—lung cancer	0.000104	0.000726	CcSEcCtD
Nicardipine—Pain—Cisplatin—lung cancer	0.000103	0.000726	CcSEcCtD
Nicardipine—Vomiting—Vinorelbine—lung cancer	0.000103	0.000721	CcSEcCtD
Nicardipine—Body temperature increased—Gemcitabine—lung cancer	0.000103	0.00072	CcSEcCtD
Nicardipine—Rash—Vinorelbine—lung cancer	0.000102	0.000715	CcSEcCtD
Nicardipine—Dermatitis—Vinorelbine—lung cancer	0.000102	0.000714	CcSEcCtD
Nicardipine—Hypotension—Paclitaxel—lung cancer	0.000101	0.000712	CcSEcCtD
Nicardipine—Headache—Vinorelbine—lung cancer	0.000101	0.00071	CcSEcCtD
Nicardipine—Syncope—Docetaxel—lung cancer	0.000101	0.00071	CcSEcCtD
Nicardipine—Conjunctivitis—Methotrexate—lung cancer	0.000101	0.00071	CcSEcCtD
Nicardipine—Sweating—Methotrexate—lung cancer	9.97e-05	0.0007	CcSEcCtD
Nicardipine—Palpitations—Docetaxel—lung cancer	9.97e-05	0.0007	CcSEcCtD
Nicardipine—Feeling abnormal—Cisplatin—lung cancer	9.96e-05	0.000699	CcSEcCtD
Nicardipine—Paraesthesia—Etoposide—lung cancer	9.95e-05	0.000698	CcSEcCtD
Nicardipine—Haematuria—Methotrexate—lung cancer	9.92e-05	0.000696	CcSEcCtD
Nicardipine—Loss of consciousness—Docetaxel—lung cancer	9.91e-05	0.000696	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Paclitaxel—lung cancer	9.9e-05	0.000694	CcSEcCtD
Nicardipine—Dyspnoea—Etoposide—lung cancer	9.88e-05	0.000693	CcSEcCtD
Nicardipine—Somnolence—Etoposide—lung cancer	9.85e-05	0.000691	CcSEcCtD
Nicardipine—Angina pectoris—Doxorubicin—lung cancer	9.84e-05	0.000691	CcSEcCtD
Nicardipine—Felodipine—ABCB1—lung cancer	9.84e-05	0.0264	CrCbGaD
Nicardipine—Insomnia—Paclitaxel—lung cancer	9.82e-05	0.000689	CcSEcCtD
Nicardipine—Hypersensitivity—Irinotecan—lung cancer	9.81e-05	0.000689	CcSEcCtD
Nicardipine—Paraesthesia—Paclitaxel—lung cancer	9.75e-05	0.000684	CcSEcCtD
Nicardipine—Hypertension—Docetaxel—lung cancer	9.74e-05	0.000684	CcSEcCtD
Nicardipine—Dyspnoea—Paclitaxel—lung cancer	9.68e-05	0.00068	CcSEcCtD
Nicardipine—Somnolence—Paclitaxel—lung cancer	9.66e-05	0.000678	CcSEcCtD
Nicardipine—Chest pain—Docetaxel—lung cancer	9.6e-05	0.000674	CcSEcCtD
Nicardipine—Arthralgia—Docetaxel—lung cancer	9.6e-05	0.000674	CcSEcCtD
Nicardipine—Myalgia—Docetaxel—lung cancer	9.6e-05	0.000674	CcSEcCtD
Nicardipine—Nausea—Vinorelbine—lung cancer	9.59e-05	0.000673	CcSEcCtD
Nicardipine—Dyspepsia—Paclitaxel—lung cancer	9.56e-05	0.000671	CcSEcCtD
Nicardipine—Body temperature increased—Cisplatin—lung cancer	9.56e-05	0.000671	CcSEcCtD
Nicardipine—Asthenia—Irinotecan—lung cancer	9.56e-05	0.000671	CcSEcCtD
Nicardipine—Nifedipine—ABCB1—lung cancer	9.52e-05	0.0255	CrCbGaD
Nicardipine—Pain—Etoposide—lung cancer	9.47e-05	0.000665	CcSEcCtD
Nicardipine—Constipation—Etoposide—lung cancer	9.47e-05	0.000665	CcSEcCtD
Nicardipine—Dry mouth—Docetaxel—lung cancer	9.39e-05	0.000659	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—lung cancer	9.33e-05	0.000655	CcSEcCtD
Nicardipine—Asthenia—Gemcitabine—lung cancer	9.31e-05	0.000653	CcSEcCtD
Nicardipine—Constipation—Paclitaxel—lung cancer	9.29e-05	0.000652	CcSEcCtD
Nicardipine—Pain—Paclitaxel—lung cancer	9.29e-05	0.000652	CcSEcCtD
Nicardipine—Confusional state—Docetaxel—lung cancer	9.28e-05	0.000651	CcSEcCtD
Nicardipine—Oedema—Docetaxel—lung cancer	9.21e-05	0.000646	CcSEcCtD
Nicardipine—Infection—Docetaxel—lung cancer	9.15e-05	0.000642	CcSEcCtD
Nicardipine—Feeling abnormal—Etoposide—lung cancer	9.13e-05	0.000641	CcSEcCtD
Nicardipine—Diarrhoea—Irinotecan—lung cancer	9.11e-05	0.00064	CcSEcCtD
Nicardipine—Gastrointestinal pain—Etoposide—lung cancer	9.06e-05	0.000636	CcSEcCtD
Nicardipine—Shock—Docetaxel—lung cancer	9.06e-05	0.000636	CcSEcCtD
Nicardipine—Thrombocytopenia—Docetaxel—lung cancer	9.01e-05	0.000633	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—lung cancer	9e-05	0.000632	CcSEcCtD
Nicardipine—Tachycardia—Docetaxel—lung cancer	8.99e-05	0.000631	CcSEcCtD
Nicardipine—Feeling abnormal—Paclitaxel—lung cancer	8.95e-05	0.000628	CcSEcCtD
Nicardipine—Hypersensitivity—Cisplatin—lung cancer	8.91e-05	0.000625	CcSEcCtD
Nicardipine—Gastrointestinal pain—Paclitaxel—lung cancer	8.88e-05	0.000623	CcSEcCtD
Nicardipine—Diarrhoea—Gemcitabine—lung cancer	8.88e-05	0.000623	CcSEcCtD
Nicardipine—Dizziness—Irinotecan—lung cancer	8.81e-05	0.000618	CcSEcCtD
Nicardipine—Body temperature increased—Etoposide—lung cancer	8.76e-05	0.000615	CcSEcCtD
Nicardipine—Abdominal pain—Etoposide—lung cancer	8.76e-05	0.000615	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—lung cancer	8.76e-05	0.000615	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—lung cancer	8.71e-05	0.000611	CcSEcCtD
Nicardipine—Asthenia—Cisplatin—lung cancer	8.68e-05	0.000609	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—lung cancer	8.64e-05	0.000606	CcSEcCtD
Nicardipine—Hypotension—Docetaxel—lung cancer	8.6e-05	0.000604	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—lung cancer	8.59e-05	0.000603	CcSEcCtD
Nicardipine—Abdominal pain—Paclitaxel—lung cancer	8.59e-05	0.000603	CcSEcCtD
Nicardipine—Body temperature increased—Paclitaxel—lung cancer	8.59e-05	0.000603	CcSEcCtD
Nicardipine—Vomiting—Irinotecan—lung cancer	8.47e-05	0.000594	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—lung cancer	8.45e-05	0.000593	CcSEcCtD
Nicardipine—Rash—Irinotecan—lung cancer	8.4e-05	0.000589	CcSEcCtD
Nicardipine—Dermatitis—Irinotecan—lung cancer	8.39e-05	0.000589	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Docetaxel—lung cancer	8.39e-05	0.000589	CcSEcCtD
Nicardipine—Headache—Irinotecan—lung cancer	8.34e-05	0.000586	CcSEcCtD
Nicardipine—Insomnia—Docetaxel—lung cancer	8.33e-05	0.000584	CcSEcCtD
Nicardipine—Diarrhoea—Cisplatin—lung cancer	8.27e-05	0.000581	CcSEcCtD
Nicardipine—Paraesthesia—Docetaxel—lung cancer	8.27e-05	0.00058	CcSEcCtD
Nicardipine—Vomiting—Gemcitabine—lung cancer	8.25e-05	0.000579	CcSEcCtD
Nicardipine—Dyspnoea—Docetaxel—lung cancer	8.21e-05	0.000576	CcSEcCtD
Nicardipine—Somnolence—Docetaxel—lung cancer	8.18e-05	0.000574	CcSEcCtD
Nicardipine—Rash—Gemcitabine—lung cancer	8.18e-05	0.000574	CcSEcCtD
Nicardipine—Dermatitis—Gemcitabine—lung cancer	8.17e-05	0.000574	CcSEcCtD
Nicardipine—Hypersensitivity—Etoposide—lung cancer	8.16e-05	0.000573	CcSEcCtD
Nicardipine—Headache—Gemcitabine—lung cancer	8.13e-05	0.00057	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—lung cancer	8.11e-05	0.000569	CcSEcCtD
Nicardipine—Dyspepsia—Docetaxel—lung cancer	8.1e-05	0.000569	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—lung cancer	8.05e-05	0.000565	CcSEcCtD
Nicardipine—Hypersensitivity—Paclitaxel—lung cancer	8e-05	0.000562	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—lung cancer	7.97e-05	0.000559	CcSEcCtD
Nicardipine—Asthenia—Etoposide—lung cancer	7.95e-05	0.000558	CcSEcCtD
Nicardipine—Nausea—Irinotecan—lung cancer	7.91e-05	0.000555	CcSEcCtD
Nicardipine—Pain—Docetaxel—lung cancer	7.87e-05	0.000553	CcSEcCtD
Nicardipine—Constipation—Docetaxel—lung cancer	7.87e-05	0.000553	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—lung cancer	7.79e-05	0.000547	CcSEcCtD
Nicardipine—Asthenia—Paclitaxel—lung cancer	7.79e-05	0.000547	CcSEcCtD
Nicardipine—Nausea—Gemcitabine—lung cancer	7.71e-05	0.000541	CcSEcCtD
Nicardipine—Vomiting—Cisplatin—lung cancer	7.69e-05	0.00054	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—lung cancer	7.66e-05	0.000538	CcSEcCtD
Nicardipine—Rash—Cisplatin—lung cancer	7.62e-05	0.000535	CcSEcCtD
Nicardipine—Dermatitis—Cisplatin—lung cancer	7.62e-05	0.000535	CcSEcCtD
Nicardipine—Feeling abnormal—Docetaxel—lung cancer	7.59e-05	0.000532	CcSEcCtD
Nicardipine—Diarrhoea—Etoposide—lung cancer	7.58e-05	0.000532	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—lung cancer	7.54e-05	0.000529	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—lung cancer	7.54e-05	0.000529	CcSEcCtD
Nicardipine—Gastrointestinal pain—Docetaxel—lung cancer	7.53e-05	0.000528	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—lung cancer	7.51e-05	0.000527	CcSEcCtD
Nicardipine—Diarrhoea—Paclitaxel—lung cancer	7.43e-05	0.000522	CcSEcCtD
Nicardipine—ABCB1—lymph node—lung cancer	7.42e-05	0.00286	CbGeAlD
Nicardipine—Malaise—Methotrexate—lung cancer	7.33e-05	0.000515	CcSEcCtD
Nicardipine—Dizziness—Etoposide—lung cancer	7.33e-05	0.000514	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—lung cancer	7.3e-05	0.000513	CcSEcCtD
Nicardipine—Abdominal pain—Docetaxel—lung cancer	7.28e-05	0.000511	CcSEcCtD
Nicardipine—Body temperature increased—Docetaxel—lung cancer	7.28e-05	0.000511	CcSEcCtD
Nicardipine—Dizziness—Paclitaxel—lung cancer	7.18e-05	0.000504	CcSEcCtD
Nicardipine—Nausea—Cisplatin—lung cancer	7.18e-05	0.000504	CcSEcCtD
Nicardipine—Vomiting—Etoposide—lung cancer	7.04e-05	0.000494	CcSEcCtD
Nicardipine—Rash—Etoposide—lung cancer	6.98e-05	0.00049	CcSEcCtD
Nicardipine—Dermatitis—Etoposide—lung cancer	6.98e-05	0.00049	CcSEcCtD
Nicardipine—Headache—Etoposide—lung cancer	6.94e-05	0.000487	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—lung cancer	6.92e-05	0.000486	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—lung cancer	6.92e-05	0.000486	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—lung cancer	6.92e-05	0.000486	CcSEcCtD
Nicardipine—Tension—Doxorubicin—lung cancer	6.91e-05	0.000485	CcSEcCtD
Nicardipine—Vomiting—Paclitaxel—lung cancer	6.91e-05	0.000485	CcSEcCtD
Nicardipine—Rash—Paclitaxel—lung cancer	6.85e-05	0.000481	CcSEcCtD
Nicardipine—Dermatitis—Paclitaxel—lung cancer	6.84e-05	0.00048	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—lung cancer	6.84e-05	0.00048	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—lung cancer	6.84e-05	0.00048	CcSEcCtD
Nicardipine—Headache—Paclitaxel—lung cancer	6.8e-05	0.000478	CcSEcCtD
Nicardipine—Hypersensitivity—Docetaxel—lung cancer	6.78e-05	0.000476	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—lung cancer	6.69e-05	0.00047	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—lung cancer	6.63e-05	0.000466	CcSEcCtD
Nicardipine—Asthenia—Docetaxel—lung cancer	6.61e-05	0.000464	CcSEcCtD
Nicardipine—Infection—Methotrexate—lung cancer	6.59e-05	0.000463	CcSEcCtD
Nicardipine—Nausea—Etoposide—lung cancer	6.58e-05	0.000462	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—lung cancer	6.53e-05	0.000458	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—lung cancer	6.5e-05	0.000456	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—lung cancer	6.47e-05	0.000454	CcSEcCtD
Nicardipine—Nausea—Paclitaxel—lung cancer	6.45e-05	0.000453	CcSEcCtD
Nicardipine—Hyperhidrosis—Methotrexate—lung cancer	6.41e-05	0.00045	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—lung cancer	6.35e-05	0.000446	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—lung cancer	6.33e-05	0.000444	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—lung cancer	6.31e-05	0.000443	CcSEcCtD
Nicardipine—Diarrhoea—Docetaxel—lung cancer	6.3e-05	0.000442	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—lung cancer	6.22e-05	0.000437	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—lung cancer	6.2e-05	0.000435	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—lung cancer	6.19e-05	0.000434	CcSEcCtD
Nicardipine—Dizziness—Docetaxel—lung cancer	6.09e-05	0.000427	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—lung cancer	6.08e-05	0.000427	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—lung cancer	6.05e-05	0.000424	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—lung cancer	6e-05	0.000421	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—lung cancer	5.99e-05	0.000421	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—lung cancer	5.99e-05	0.000421	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—lung cancer	5.99e-05	0.000421	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—lung cancer	5.97e-05	0.000419	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—lung cancer	5.96e-05	0.000418	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—lung cancer	5.92e-05	0.000416	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—lung cancer	5.92e-05	0.000415	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—lung cancer	5.9e-05	0.000414	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—lung cancer	5.86e-05	0.000411	CcSEcCtD
Nicardipine—Vomiting—Docetaxel—lung cancer	5.85e-05	0.000411	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—lung cancer	5.84e-05	0.00041	CcSEcCtD
Nicardipine—Rash—Docetaxel—lung cancer	5.8e-05	0.000407	CcSEcCtD
Nicardipine—Dermatitis—Docetaxel—lung cancer	5.8e-05	0.000407	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—lung cancer	5.79e-05	0.000407	CcSEcCtD
Nicardipine—Headache—Docetaxel—lung cancer	5.77e-05	0.000405	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—lung cancer	5.75e-05	0.000403	CcSEcCtD
Nicardipine—Infection—Doxorubicin—lung cancer	5.71e-05	0.000401	CcSEcCtD
Nicardipine—Pain—Methotrexate—lung cancer	5.67e-05	0.000398	CcSEcCtD
Nicardipine—Shock—Doxorubicin—lung cancer	5.65e-05	0.000397	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—lung cancer	5.63e-05	0.000395	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—lung cancer	5.61e-05	0.000394	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—lung cancer	5.55e-05	0.00039	CcSEcCtD
Nicardipine—Nausea—Docetaxel—lung cancer	5.47e-05	0.000384	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—lung cancer	5.47e-05	0.000384	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—lung cancer	5.43e-05	0.000381	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—lung cancer	5.37e-05	0.000377	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—lung cancer	5.25e-05	0.000368	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—lung cancer	5.25e-05	0.000368	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.23e-05	0.000367	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—lung cancer	5.2e-05	0.000365	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—lung cancer	5.16e-05	0.000362	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—lung cancer	5.12e-05	0.00036	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—lung cancer	5.11e-05	0.000358	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—lung cancer	5.06e-05	0.000355	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—lung cancer	4.91e-05	0.000345	CcSEcCtD
Nicardipine—Pain—Doxorubicin—lung cancer	4.91e-05	0.000345	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—lung cancer	4.89e-05	0.000343	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—lung cancer	4.76e-05	0.000334	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—lung cancer	4.73e-05	0.000332	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—lung cancer	4.7e-05	0.00033	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—lung cancer	4.54e-05	0.000319	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—lung cancer	4.54e-05	0.000319	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—lung cancer	4.54e-05	0.000319	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—lung cancer	4.39e-05	0.000308	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—lung cancer	4.23e-05	0.000297	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—lung cancer	4.22e-05	0.000296	CcSEcCtD
Nicardipine—Rash—Methotrexate—lung cancer	4.18e-05	0.000294	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—lung cancer	4.18e-05	0.000293	CcSEcCtD
Nicardipine—Headache—Methotrexate—lung cancer	4.16e-05	0.000292	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—lung cancer	4.12e-05	0.000289	CcSEcCtD
Nicardipine—Nausea—Methotrexate—lung cancer	3.94e-05	0.000277	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—lung cancer	3.93e-05	0.000276	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—lung cancer	3.8e-05	0.000267	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—lung cancer	3.65e-05	0.000256	CcSEcCtD
Nicardipine—Rash—Doxorubicin—lung cancer	3.62e-05	0.000254	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—lung cancer	3.62e-05	0.000254	CcSEcCtD
Nicardipine—Headache—Doxorubicin—lung cancer	3.6e-05	0.000253	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—lung cancer	3.41e-05	0.00024	CcSEcCtD
Nicardipine—CYP3A5—Metabolism—EP300—lung cancer	1.3e-06	8.3e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EP300—lung cancer	1.29e-06	8.28e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—EP300—lung cancer	1.29e-06	8.27e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EP300—lung cancer	1.29e-06	8.26e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTM1—lung cancer	1.28e-06	8.23e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	1.28e-06	8.22e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ERBB2—lung cancer	1.28e-06	8.22e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ERBB2—lung cancer	1.28e-06	8.22e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CD—lung cancer	1.28e-06	8.22e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	1.28e-06	8.18e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EP300—lung cancer	1.28e-06	8.18e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EP300—lung cancer	1.27e-06	8.15e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CD—lung cancer	1.27e-06	8.15e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—lung cancer	1.27e-06	8.14e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—lung cancer	1.27e-06	8.14e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MTOR—lung cancer	1.27e-06	8.11e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MTOR—lung cancer	1.27e-06	8.11e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CB—lung cancer	1.27e-06	8.11e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CB—lung cancer	1.27e-06	8.11e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ALB—lung cancer	1.27e-06	8.11e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL8—lung cancer	1.26e-06	8.06e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SRC—lung cancer	1.26e-06	8.05e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—lung cancer	1.26e-06	8.05e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—lung cancer	1.26e-06	8.05e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ALB—lung cancer	1.25e-06	8.04e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SRC—lung cancer	1.25e-06	8.03e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—lung cancer	1.25e-06	8.01e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—lung cancer	1.25e-06	8e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—EP300—lung cancer	1.25e-06	8e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—EP300—lung cancer	1.25e-06	8e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SRC—lung cancer	1.24e-06	7.95e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—lung cancer	1.24e-06	7.95e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SRC—lung cancer	1.24e-06	7.93e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—lung cancer	1.23e-06	7.91e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—lung cancer	1.23e-06	7.91e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.22e-06	7.84e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—lung cancer	1.22e-06	7.82e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—lung cancer	1.22e-06	7.82e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CYP1A1—lung cancer	1.22e-06	7.8e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL8—lung cancer	1.22e-06	7.8e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL8—lung cancer	1.22e-06	7.8e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CB—lung cancer	1.21e-06	7.79e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—lung cancer	1.21e-06	7.77e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NRAS—lung cancer	1.21e-06	7.75e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—lung cancer	1.21e-06	7.75e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—lung cancer	1.21e-06	7.75e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.21e-06	7.74e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—lung cancer	1.21e-06	7.74e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ERCC2—lung cancer	1.21e-06	7.74e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NRAS—lung cancer	1.2e-06	7.72e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	1.2e-06	7.72e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—lung cancer	1.2e-06	7.72e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—lung cancer	1.2e-06	7.72e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—lung cancer	1.2e-06	7.71e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—lung cancer	1.2e-06	7.7e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—lung cancer	1.2e-06	7.69e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—lung cancer	1.2e-06	7.69e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—lung cancer	1.2e-06	7.67e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—lung cancer	1.2e-06	7.67e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—lung cancer	1.19e-06	7.65e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—lung cancer	1.19e-06	7.65e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NRAS—lung cancer	1.19e-06	7.65e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—lung cancer	1.19e-06	7.65e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NRAS—lung cancer	1.19e-06	7.63e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CB—lung cancer	1.19e-06	7.6e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—lung cancer	1.18e-06	7.57e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—lung cancer	1.18e-06	7.54e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—lung cancer	1.17e-06	7.53e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—lung cancer	1.17e-06	7.51e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—JUN—lung cancer	1.17e-06	7.49e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—lung cancer	1.16e-06	7.46e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—lung cancer	1.16e-06	7.46e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—lung cancer	1.16e-06	7.45e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—lung cancer	1.16e-06	7.45e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—lung cancer	1.16e-06	7.42e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.16e-06	7.42e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—lung cancer	1.16e-06	7.41e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—lung cancer	1.16e-06	7.41e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK3—lung cancer	1.15e-06	7.4e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.15e-06	7.39e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.14e-06	7.33e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—lung cancer	1.14e-06	7.32e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.14e-06	7.31e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—lung cancer	1.14e-06	7.3e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—lung cancer	1.14e-06	7.3e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—lung cancer	1.14e-06	7.29e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1A—lung cancer	1.13e-06	7.26e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—lung cancer	1.13e-06	7.26e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—lung cancer	1.13e-06	7.26e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—JUN—lung cancer	1.13e-06	7.25e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—JUN—lung cancer	1.13e-06	7.25e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—lung cancer	1.13e-06	7.25e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—lung cancer	1.13e-06	7.24e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—lung cancer	1.13e-06	7.22e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—lung cancer	1.12e-06	7.19e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—EP300—lung cancer	1.12e-06	7.19e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.12e-06	7.16e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—lung cancer	1.11e-06	7.12e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—lung cancer	1.11e-06	7.11e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—lung cancer	1.11e-06	7.11e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CB—lung cancer	1.11e-06	7.1e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—lung cancer	1.11e-06	7.1e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—lung cancer	1.1e-06	7.08e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—lung cancer	1.1e-06	7.08e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—lung cancer	1.1e-06	7.07e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—lung cancer	1.1e-06	7.06e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—lung cancer	1.1e-06	7.06e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—lung cancer	1.1e-06	7.06e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—lung cancer	1.1e-06	7.05e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—lung cancer	1.1e-06	7.05e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—lung cancer	1.1e-06	7.04e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—lung cancer	1.1e-06	7.04e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1A—lung cancer	1.1e-06	7.03e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1A—lung cancer	1.1e-06	7.03e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—lung cancer	1.09e-06	7.01e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—lung cancer	1.09e-06	7.01e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—lung cancer	1.09e-06	7e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—lung cancer	1.09e-06	6.97e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.08e-06	6.95e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EP300—lung cancer	1.08e-06	6.91e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—lung cancer	1.07e-06	6.84e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—lung cancer	1.07e-06	6.84e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.06e-06	6.79e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—lung cancer	1.06e-06	6.77e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—lung cancer	1.06e-06	6.77e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—lung cancer	1.05e-06	6.76e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—lung cancer	1.05e-06	6.73e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SRC—lung cancer	1.05e-06	6.72e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOA1—lung cancer	1.04e-06	6.7e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EP300—lung cancer	1.04e-06	6.69e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EP300—lung cancer	1.04e-06	6.69e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—lung cancer	1.04e-06	6.68e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—lung cancer	1.04e-06	6.67e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—lung cancer	1.04e-06	6.65e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—lung cancer	1.03e-06	6.58e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—lung cancer	1.02e-06	6.57e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—lung cancer	1.02e-06	6.57e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.02e-06	6.57e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—lung cancer	1.02e-06	6.55e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—lung cancer	1.02e-06	6.54e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—lung cancer	1.02e-06	6.54e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SRC—lung cancer	1.01e-06	6.5e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SRC—lung cancer	1.01e-06	6.5e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—lung cancer	1.01e-06	6.48e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NRAS—lung cancer	1.01e-06	6.47e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—lung cancer	1.01e-06	6.47e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—lung cancer	1.01e-06	6.46e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—EP300—lung cancer	1e-06	6.42e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—lung cancer	9.88e-07	6.33e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—lung cancer	9.88e-07	6.33e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—lung cancer	9.8e-07	6.28e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—lung cancer	9.8e-07	6.28e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—lung cancer	9.78e-07	6.27e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—lung cancer	9.78e-07	6.27e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—EP300—lung cancer	9.77e-07	6.27e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NRAS—lung cancer	9.76e-07	6.26e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NRAS—lung cancer	9.76e-07	6.26e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—lung cancer	9.76e-07	6.26e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—lung cancer	9.76e-07	6.26e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—lung cancer	9.75e-07	6.25e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—lung cancer	9.75e-07	6.25e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK3—lung cancer	9.66e-07	6.19e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—lung cancer	9.66e-07	6.19e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—lung cancer	9.6e-07	6.15e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—lung cancer	9.58e-07	6.14e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—lung cancer	9.57e-07	6.14e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	9.56e-07	6.13e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—lung cancer	9.54e-07	6.12e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—lung cancer	9.53e-07	6.11e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—lung cancer	9.53e-07	6.11e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	9.43e-07	6.05e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	9.41e-07	6.03e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—lung cancer	9.4e-07	6.02e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—lung cancer	9.38e-07	6.01e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK3—lung cancer	9.34e-07	5.99e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK3—lung cancer	9.34e-07	5.99e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—lung cancer	9.31e-07	5.97e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—lung cancer	9.3e-07	5.97e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—lung cancer	9.25e-07	5.93e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—lung cancer	9.23e-07	5.92e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—lung cancer	9.23e-07	5.92e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—lung cancer	9.22e-07	5.91e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—EP300—lung cancer	9.21e-07	5.9e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—lung cancer	9.19e-07	5.89e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—EP300—lung cancer	9.13e-07	5.85e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—lung cancer	9.13e-07	5.85e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—lung cancer	9.1e-07	5.84e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—lung cancer	9.09e-07	5.83e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—lung cancer	9.09e-07	5.83e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—POMC—lung cancer	9.08e-07	5.82e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—lung cancer	9e-07	5.77e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—lung cancer	9e-07	5.77e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—lung cancer	8.89e-07	5.7e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—lung cancer	8.89e-07	5.7e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—lung cancer	8.84e-07	5.67e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CREBBP—lung cancer	8.84e-07	5.67e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—lung cancer	8.81e-07	5.65e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—lung cancer	8.73e-07	5.6e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—lung cancer	8.7e-07	5.58e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—lung cancer	8.68e-07	5.57e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—lung cancer	8.65e-07	5.55e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—lung cancer	8.46e-07	5.43e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—lung cancer	8.44e-07	5.41e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—lung cancer	8.4e-07	5.38e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—lung cancer	8.4e-07	5.38e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CD—lung cancer	8.38e-07	5.37e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—lung cancer	8.35e-07	5.36e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—lung cancer	8.33e-07	5.34e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—lung cancer	8.3e-07	5.32e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ALB—lung cancer	8.27e-07	5.3e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—lung cancer	8.01e-07	5.13e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—lung cancer	7.98e-07	5.11e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—lung cancer	7.84e-07	5.03e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—lung cancer	7.83e-07	5.02e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—lung cancer	7.81e-07	5.01e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—lung cancer	7.79e-07	5e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—lung cancer	7.78e-07	4.99e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—lung cancer	7.72e-07	4.95e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—lung cancer	7.72e-07	4.95e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—lung cancer	7.72e-07	4.95e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—lung cancer	7.71e-07	4.94e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—lung cancer	7.69e-07	4.93e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—lung cancer	7.54e-07	4.83e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—lung cancer	7.54e-07	4.83e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—lung cancer	7.46e-07	4.79e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—lung cancer	7.46e-07	4.79e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—lung cancer	7.41e-07	4.75e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—lung cancer	7.38e-07	4.73e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CB—lung cancer	7.31e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—lung cancer	7.24e-07	4.64e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—lung cancer	7.23e-07	4.63e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—lung cancer	7.14e-07	4.58e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—lung cancer	7.14e-07	4.58e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—lung cancer	7.06e-07	4.53e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—lung cancer	6.83e-07	4.38e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—lung cancer	6.83e-07	4.38e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—lung cancer	6.81e-07	4.37e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—lung cancer	6.78e-07	4.35e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—lung cancer	6.75e-07	4.33e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—lung cancer	6.52e-07	4.18e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—lung cancer	6.31e-07	4.05e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—lung cancer	6.3e-07	4.04e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—lung cancer	6.3e-07	4.04e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—lung cancer	6.05e-07	3.88e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—EP300—lung cancer	6.02e-07	3.86e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—lung cancer	5.91e-07	3.79e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—lung cancer	5.56e-07	3.57e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—lung cancer	5.52e-07	3.54e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—lung cancer	4.45e-07	2.86e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—lung cancer	3.64e-07	2.33e-06	CbGpPWpGaD
